Literature DB >> 24992123

Evaluation of the impact of a pertussis cocooning program on infant pertussis infection.

C Mary Healy1, Marcia A Rench, Susan H Wootton, Luis A Castagnini.   

Abstract

BACKGROUND: Tetanus, diphtheria and acellular pertussis immunization of infant contacts (cocooning) is recommended by the Centers for Disease Control and Prevention to prevent infant pertussis. We determined whether implementing a cocooning program at Ben Taub General Hospital, Houston, reduced severe pertussis in young infants.
METHODS: Infants ≤6 months of age, diagnosed with pertussis (determined by International Classification of Diseases, Ninth Revision codes and microbiology records) at 4 hospitals, and born at times when only postpartum women (January 2008 through May 2009) and all infant contacts (June 2009 through August 2011) were offered tetanus, diphtheria and acellular pertussis vaccine at Ben Taub General Hospital were compared with infants born preintervention (May 2004 through December 2007).
RESULTS: One hundred ninety-six (49%) infants with pertussis were born preintervention, 140 (35%) during maternal postpartum (PP) and 64 (16%) during cocooning (C) periods. Infants were similar in age at diagnosis (81.2 vs. 71.3 [PP] vs. 72.5 [C] days; P 0.07), sex (male 59% vs. 51% [PP] vs. 48% [C]; P 0.17), hospitalization (68% vs. 71% [PP] vs. 78% [C]; P 0.27) and outcome (2 deaths in the PP period; P 0.15), but more were admitted to intensive care units during cocooning (24% vs. 35% [PP] vs. 68% [C]; P < 0.001). Similar proportions of infants were born at Ben Taub General Hospital throughout the study (8% vs. 9% [PP] vs. 5% [C]; P 0.53).
CONCLUSIONS: Postpartum immunization and cocooning did not reduce pertussis illness in infants ≤6 months of age. Efforts should be directed toward increasing tetanus, diphtheria and acellular pertussis immunization during pregnancy, combined with cocooning, to reduce life-threatening young infant pertussis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24992123     DOI: 10.1097/INF.0000000000000486

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  20 in total

1.  Clinician perspectives on strategies to improve patient maternal immunization acceptability in obstetrics and gynecology practice settings.

Authors:  Paula M Frew; Laura A Randall; Fauzia Malik; Rupali J Limaye; Andrew Wilson; Sean T O'Leary; Daniel Salmon; Meghan Donnelly; Kevin Ault; Matthew Z Dudley; Vincent L Fenimore; Saad B Omer
Journal:  Hum Vaccin Immunother       Date:  2018-02-15       Impact factor: 3.452

2.  Questionnaire survey on maternal pertussis vaccination for pregnant women and mothers in Nara prefecture, Japan.

Authors:  Taito Kitano; Tomoko Onishi; Masahiro Takeyama; Midori Shima
Journal:  Hum Vaccin Immunother       Date:  2019-09-05       Impact factor: 3.452

3.  The impact of past vaccination coverage and immunity on pertussis resurgence.

Authors:  Matthieu Domenech de Cellès; Felicia M G Magpantay; Aaron A King; Pejman Rohani
Journal:  Sci Transl Med       Date:  2018-03-28       Impact factor: 17.956

4.  Epidemiological and Economic Effects of Priming With the Whole-Cell Bordetella pertussis Vaccine.

Authors:  Haedi DeAngelis; Samuel V Scarpino; Meagan C Fitzpatrick; Alison P Galvani; Benjamin M Althouse
Journal:  JAMA Pediatr       Date:  2016-05-01       Impact factor: 16.193

5.  An Assessment of the Cocooning Strategy for Preventing Infant Pertussis-United States, 2011.

Authors:  Amy E Blain; Melissa Lewis; Emily Banerjee; Kathy Kudish; Juventila Liko; Suzanne McGuire; David Selvage; James Watt; Stacey W Martin; Tami H Skoff
Journal:  Clin Infect Dis       Date:  2016-12-01       Impact factor: 9.079

Review 6.  Pertussis vaccination in pregnancy.

Authors:  C Mary Healy
Journal:  Hum Vaccin Immunother       Date:  2016-07-06       Impact factor: 3.452

7.  Lessons from a mature acellular pertussis vaccination program and strategies to overcome suboptimal vaccine effectiveness.

Authors:  Ousseny Zerbo; Bruce Fireman; Nicola P Klein
Journal:  Expert Rev Vaccines       Date:  2021-10-08       Impact factor: 5.683

8.  Asymptomatic transmission and the resurgence of Bordetella pertussis.

Authors:  Benjamin M Althouse; Samuel V Scarpino
Journal:  BMC Med       Date:  2015-06-24       Impact factor: 8.775

9.  Evaluation of outbreak response immunization in the control of pertussis using agent-based modeling.

Authors:  Alexander Doroshenko; Weicheng Qian; Nathaniel D Osgood
Journal:  PeerJ       Date:  2016-08-18       Impact factor: 2.984

Review 10.  Rediscovering Pertussis.

Authors:  Manuela Zlamy
Journal:  Front Pediatr       Date:  2016-06-08       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.